Quarterly report · Q1

Period2022-04-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥48.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥184.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥46.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥6.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥5.9bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥8.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥23.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥8.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥7.6bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.3bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥6.0bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥5.3bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥325.4bnat 2022-06-30Cons.Assets
Total assets¥315.5bnat 2022-03-31Cons.Assets
Total assets¥297.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥72.8bnat 2022-06-30Cons.Liabilities
Total liabilities¥69.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥252.5bnat 2022-06-30Cons.Net assets
Net assets / equity¥246.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥230.8bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥46.5bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥38.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥35.412022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.882021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥35.42022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥101.652021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥30.872021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio77.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.2%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥27m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥473m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥69m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥69m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥1.9bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue2022-04-01 → 2022-06-30¥21.2bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue external2022-04-01 → 2022-06-30¥21.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥12.6bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥12.6bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E00836-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥2.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue external2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥46.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥46.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥42m
—segment totalsegment profit2022-04-01 → 2022-06-30¥7.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥48.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥48.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥69m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥8.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥25m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥444m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥66m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥66m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥1.7bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue2021-04-01 → 2021-06-30¥20.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue external2021-04-01 → 2021-06-30¥20.1bn
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥40m
jpcrp040300-q1r_E00836-000Functional Chemicalsreportable segmentsegment profit2021-04-01 → 2021-06-30¥3.4bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥12.8bn
jpcrp040300-q1r_E00836-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E00836-000Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue2021-04-01 → 2021-06-30¥11.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentrevenue external2021-04-01 → 2021-06-30¥11.4bn
jpcrp040300-q1r_E00836-000Safety Systemsreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.8bn
—segment totalrevenue2021-04-01 → 2021-06-30¥44.3bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥44.2bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥40m
—segment totalsegment profit2021-04-01 → 2021-06-30¥7.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥46.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥46.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥66m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥7.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 393
ItemContextValueUnit
Foreign currency translation adjustmentCurrentQuarterInstant15933000000JPY
Remeasurements of defined benefit plansPrior1YearInstant1396000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant1310000000JPY
Valuation and translation adjustmentsPrior1YearInstant21846000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant26138000000JPY
Non controlling interestsPrior1YearInstant945000000JPY
Non controlling interestsCurrentQuarterInstant989000000JPY
Net assetsPrior1YearInstant246425000000JPY
Net assetsCurrentQuarterInstant252525000000JPY
Liabilities and net assetsPrior1YearInstant315459000000JPY
Liabilities and net assetsCurrentQuarterInstant325364000000JPY
Net salesPrior1YTDDuration46447000000JPY
Net salesCurrentYTDDuration48296000000JPY
Cost of salesPrior1YTDDuration30319000000JPY
Cost of salesCurrentYTDDuration31301000000JPY
Gross profitPrior1YTDDuration16128000000JPY
Gross profitCurrentYTDDuration16995000000JPY
Selling general and administrative expensesPrior1YTDDuration10240000000JPY
Selling general and administrative expensesCurrentYTDDuration10614000000JPY
Operating incomePrior1YTDDuration5887000000JPY
Operating incomeCurrentYTDDuration6380000000JPY
Interest income noiPrior1YTDDuration29000000JPY
Interest income noiCurrentYTDDuration91000000JPY
Dividends income noiPrior1YTDDuration413000000JPY
Dividends income noiCurrentYTDDuration442000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration149000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration-JPY
Foreign exchange gains noiPrior1YTDDuration-JPY
Foreign exchange gains noiCurrentYTDDuration1588000000JPY
Other noiPrior1YTDDuration203000000JPY
Other noiCurrentYTDDuration227000000JPY
Non operating incomePrior1YTDDuration796000000JPY
Non operating incomeCurrentYTDDuration2350000000JPY
Interest expenses noePrior1YTDDuration28000000JPY
Interest expenses noeCurrentYTDDuration24000000JPY
Equity in losses of affiliates noePrior1YTDDuration-JPY
Equity in losses of affiliates noeCurrentYTDDuration9000000JPY
Foreign exchange losses noePrior1YTDDuration253000000JPY
Foreign exchange losses noeCurrentYTDDuration-JPY
Other noePrior1YTDDuration53000000JPY
Other noeCurrentYTDDuration63000000JPY
Non operating expensesPrior1YTDDuration335000000JPY
Non operating expensesCurrentYTDDuration97000000JPY
Ordinary incomePrior1YTDDuration6348000000JPY
Ordinary incomeCurrentYTDDuration8634000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1371000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration28000000JPY
Extraordinary incomePrior1YTDDuration1371000000JPY
Extraordinary incomeCurrentYTDDuration28000000JPY
Loss on disposal of noncurrent assets elPrior1YTDDuration111000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass